|
Oct 17
|
Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024
|
|
Oct 10
|
Appili Therapeutics – Press Release Correction
|
|
Oct 10
|
Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval
|
|
Oct 10
|
Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders
|
|
Jul 25
|
Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition
|
|
Dec 6
|
APLIF: ATI-1701 Program Awarded Additional US$6.6 Million in Funding…
|
|
Sep 27
|
Appili Therapeutics Announces Results of Annual Meeting of Shareholders and Provides Corporate Update
|
|
Sep 27
|
Appili Therapeutics Presents at the 10th International Tularemia Conference
|
|
Jul 17
|
APLIF: Executes Initial Contract with USAFA for Development of ATI-1701…
|